|
1
|
Lykoudis PM, O'Reilly D, Nastos K and
Fusai G: Systematic review of surgical management of synchronous
colorectal liver metastases. Br J Surg. 101:605–612. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nordlinger B, Van Cutsem E, Gruenberger T,
Glimelius B, Poston G, Rougier P, Sobrero A and Ychou M: European
Colorectal Metastases Treatment Group; Sixth International
Colorectal Liver Metastases Workshop: Combination of surgery and
chemotherapy and the role of targeted agents in the treatment of
patients with colorectal liver metastases: Recommendations from an
expert panel. Ann Oncol. 20:985–992. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Simmonds PC, Primrose JN, Colquitt JL,
Garden OJ, Poston GJ and Rees M: Surgical resection of hepatic
metastases from colorectal cancer: A systematic review of published
studies. Br J Cancer. 94:982–999. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
van Dijk TH, Tamas K, Beukema JC, Beets
GL, Gelderblom AJ, de Jong KP, Nagtegaal ID, Rutten HJ, van de
Velde CJ, Wiggers T, et al: Evaluation of short-course radiotherapy
followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin
and subsequent radical surgical treatment in primary stage IV
rectal cancer. Ann Oncol. 24:1762–1769. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Manfredi S, Lepage C, Hatem C, Coatmeur O,
Faivre J and Bouvier AM: Epidemiology and management of liver
metastases from colorectal cancer. Ann Surg. 244:254–259. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bozzetti F, Doci R, Bignami P, Morabito A
and Gennari L: Patterns of failure following surgical resection of
colorectal cancer liver metastases. Rationale for a multimodal
approach. Ann Surg. 205:264–270. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Konopke R, Roth J, Volk A, Pistorius S,
Folprecht G, Zöphel K, Schuetze C, Laniado M, Saeger HD and
Kersting S: Colorectal liver metastases: An update on palliative
treatment options. J Gastrointestin Liver Dis. 21:83–91.
2012.PubMed/NCBI
|
|
8
|
Cummings LC, Payes JD and Cooper GS:
Survival after hepatic resection in metastatic colorectal cancer: A
population-based study. Cancer. 109:718–726. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
de Jong MC, Pulitano C, Ribero D, Strub J,
Mentha G, Schulick RD, Choti MA, Aldrighetti L, Capussotti L and
Pawlik TM: Rates and patterns of recurrence following curative
intent surgery for colorectal liver metastasis: An international
multi-institutional analysis of 1669 patients. Ann Surg.
250:440–448. 2009.PubMed/NCBI
|
|
10
|
Ruers T, Punt C, Van Coevorden F, Pierie
JP, Borel-Rinkes I, Ledermann JA, Poston G, Bechstein W, Lentz MA,
Mauer M, et al: Radiofrequency ablation combined with systemic
treatment versus systemic treatment alone in patients with
non-resectable colorectal liver metastases: a randomized EORTC
Intergroup phase II study (EORTC 40004). Ann Oncol. 23:2619–2626.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mekenkamp LJ, Koopman M, Teerenstra S, van
Krieken JH, Mol L, Nagtegaal ID and Punt CJ: Clinicopathological
features and outcome in advanced colorectal cancer patients with
synchronous vs. metachronous metastases. Br J Cancer. 103:159–164.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Siriwardena AK, Mason JM, Mullamitha S,
Hancock HC and Jegatheeswaran S: Management of colorectal cancer
presenting with synchronous liver metastases. Nat Rev Clin Oncol.
11:446–459. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Adam R: Chemotherapy and surgery: new
perspectives on the treatment of unresectable liver metastases. Ann
Oncol. 14:(Suppl 2). ii13–ii16. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nordlinger B, Van Cutsem E, Rougier P,
Köhne CH, Ychou M, Sobrero A, Adam R, Arvidsson D, Carrato A,
Georgoulias V, et al: Does chemotherapy prior to liver resection
increase the potential for cure in patients with metastatic
colorectal cancer? A report from the European Colorectal Metastases
Treatment Group. Eur J Cancer. 43:2037–2045. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nordlinger B, Sorbye H, Glimelius B,
Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole
ET, Finch-Jones M, et al: EORTC Gastro-Intestinal Tract Cancer
Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen
und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie
(ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG);
Fédération Francophone de Cancérologie Digestive (FFCD):
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery
alone for resectable liver metastases from colorectal cancer (EORTC
Intergroup trial 40983): A randomised controlled trial. Lancet.
371:1007–1016. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cunningham D, Humblet Y, Siena S, Khayat
D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype
C, et al: Cetuximab monotherapy and cetuximab plus irinotecan in
irinotecan-refractory metastatic colorectal cancer. N Engl J Med.
351:337–345. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bramhall SR, Gur U, Coldham C, Gunson BK,
Mayer AD, McMaster P, Candinas D, Buckels JA and Mirza DF: Liver
resection for colorectal metastases. Ann R Coll Surg Engl.
85:334–339. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Clavien PA, Petrowsky H, DeOliveira ML and
Graf R: Strategies for safer liver surgery and partial liver
transplantation. N Engl J Med. 356:1545–1559. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hou W and Zhu X: Extra vascular
interventional treatment of liver cancer, present and future. Drug
Discov Ther. 9:335–341. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
van Dam RM, Lodewick TM, van den Broek MA,
de Jong MC, Greve JW, Jansen RL, Bemelmans MH, Neumann UP, Damink
Olde SW and Dejong CH: Outcomes of extended versus limited
indications for patients undergoing a liver resection for
colorectal cancer liver metastases. HPB (Oxford). 16:550–559. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vauthey JN, Pawlik TM, Abdalla EK, Arens
JF, Nemr RA, Wei SH, Kennamer DL, Ellis LM and Curley SA: Is
extended hepatectomy for hepatobiliary malignancy justified? Ann
Surg. 239:722–730; discussion 730–732. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsoulfas G, Pramateftakis MG and Kanellos
I: Surgical treatment of hepatic metastases from colorectal cancer.
World J Gastrointest Oncol. 3:1–9. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pawlik TM, Abdalla EK, Ellis LM, Vauthey
JN and Curley SA: Debunking dogma: Surgery for four or more
colorectal liver metastases is justified. J Gastrointest Surg.
10:240–248. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Altendorf-Hofmann A and Scheele J: A
critical review of the major indicators of prognosis after
resection of hepatic metastases from colorectal carcinoma. Surg
Oncol Clin N Am. 12:165–192, xi. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pulitanò C, Bodingbauer M, Aldrighetti L,
de Jong MC, Castillo F, Schulick RD, Parks RW, Choti MA, Wigmore
SJ, Gruenberger T, et al: Liver resection for colorectal metastases
in presence of extrahepatic disease: Results from an international
multi-institutional analysis. Ann Surg Oncol. 18:1380–1388. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mattar RE, Al-Alem F, Simoneau E and
Hassanain M: Preoperative selection of patients with colorectal
cancer liver metastasis for hepatic resection. World J
Gastroenterol. 22:567–581. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Abdalla EK, Denys A, Chevalier P, Nemr RA
and Vauthey JN: Total and segmental liver volume variations:
Implications for liver surgery. Surgery. 135:404–410. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chang GJ: Challenge of primary tumor
management in patients with stage IV colorectal cancer. J Clin
Oncol. 30:3165–3166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Choti MA, Sitzmann JV, Tiburi MF,
Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ and
Cameron JL: Trends in long-term survival following liver resection
for hepatic colorectal metastases. Ann Surg. 235:759–766. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fong Y, Fortner J, Sun RL, Brennan MF and
Blumgart LH: Clinical score for predicting recurrence after hepatic
resection for metastatic colorectal cancer: Analysis of 1001
consecutive cases. Ann Surg. 230:309–318; discussion 318–321. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kemeny N, Kemeny MM and Lawrence TS: Liver
metastasesClinical Oncology. Abeloff MD, Armitage JO, Lichter AS
and Niederhuber JE: Churchill Livingstone; New York: pp. 886–921.
2000
|
|
34
|
National Comprehensive Cancer Network:
Colon cancer guidelines version 3. 2012.(28/9/2014). http://www.nccn.org/professionals/physician_gls/pdf/colorectal_screening.pdf
|
|
35
|
Bai H, Huangz X, Jing L, Zeng Q and Han L:
The effect of radiofrequency ablation vs. liver resection on
survival outcome of colorectal liver metastases (CRLM): A
meta-analysis. Hepatogastroenterology. 62:373–377. 2015.PubMed/NCBI
|
|
36
|
Gruenberger Th, Gruenberger B, Becherer A,
Kettenbach J, Dieckmann K and Schima W: Interdisciplinary
management of colorectal cancer liver metastases. Eur Surg.
38:107–111. 2006. View Article : Google Scholar
|
|
37
|
Viganò L, Capussotti L, De Rosa G, De
Saussure WO, Mentha G and Rubbia-Brandt L: Liver resection for
colorectal metastases after chemotherapy: Impact of
chemotherapy-related liver injuries, pathological tumor response,
and micrometastases on long-term survival. Ann Surg. 258:731–742.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Adam R, Pascal G, Castaing D, Azoulay D,
Delvart V, Paule B, Levi F and Bismuth H: Tumor progression while
on chemotherapy: A contraindication to liver resection for multiple
colorectal metastases? Ann Surg. 240:1052–1064. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gruenberger B, Scheithauer W, Punzengruber
R, Zielinski C, Tamandl D and Gruenberger T: Importance of response
to neoadjuvant chemotherapy in potentially curable colorectal
cancer liver metastases. BMC Cancer. 8:1202008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Khan AZ, Morris-Stiff G and Makuuchi M:
Patterns of chemotherapy-induced hepatic injury and their
implications for patients undergoing liver resection for colorectal
liver metastases. J Hepatobiliary Pancreat Surg. 16:137–144. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Aloia T, Sebagh M, Plasse M, Karam V, Lévi
F, Giacchetti S, Azoulay D, Bismuth H, Castaing D and Adam R: Liver
histology and surgical outcomes after preoperative chemotherapy
with fluorouracil plus oxaliplatin in colorectal cancer liver
metastases. J Clin Oncol. 24:4983–4990. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pulitanò C, Aldrighetti L, Arru M, Vitali
G, Ronzoni M, Catena M, Finazzi R, Villa E and Ferla G: Influence
of preoperative chemotherapy on the risk of major hepatectomy for
colorectal liver metastases. Ann Surg. 244:833–835; author reply
835. 2006. View Article : Google Scholar
|
|
43
|
Khoo E, O'Neill S, Brown E, Wigmore SJ and
Harrison EM: Systematic review of systemic adjuvant, neoadjuvant
and perioperative chemotherapy for resectable colorectal-liver
metastases. HPB (Oxford). 18:485–493. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Primrose J, Falk S, Finch-Jones M, Valle
J, O'Reilly D, Siriwardena A, Hornbuckle J, Peterson M, Rees M,
Iveson T, et al: Systemic chemotherapy with or without cetuximab in
patients with resectable colorectal liver metastasis: The New EPOC
randomised controlled trial. Lancet Oncol. 15:601–611. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fujita S, Akasu T and Moriya Y: Resection
of synchronous liver metastases from colorectal cancer. Jpn J Clin
Oncol. 30:7–11. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tanaka K, Shimada H, Matsuo K, Nagano Y,
Endo I, Sekido H and Togo S: Outcome after simultaneous colorectal
and hepatic resection for colorectal cancer with synchronous
metastases. Surgery. 136:650–659. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Martin R, Paty P, Fong Y, Grace A, Cohen
A, DeMatteo R, Jarnagin W and Blumgart L: Simultaneous liver and
colorectal resections are safe for synchronous colorectal liver
metastasis. J Am Coll Surg. 197:233–241; discussion 241. –242.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chua HK, Sondenaa K, Tsiotos GG, Larson
DR, Wolff BG and Nagorney DM: Concurrent vs. staged colectomy and
hepatectomy for primary colorectal cancer with synchronous hepatic
metastases. Dis Colon Rectum. 47:1310–1316. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Silberhumer GR, Paty PB, Denton B, Guillem
J, Gonen M, Araujo RL, Nash GM, Temple LK, Allen PJ, DeMatteo RP,
et al: Long-term oncologic outcomes for simultaneous resection of
synchronous metastatic liver and primary colorectal cancer.
Surgery. 160:67–73. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jaeck D and Pessaux P: Bilobar colorectal
liver metastases: Treatment options. Surg Oncol Clin N Am.
17:553–568, ix. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sharma S, Camci C and Jabbour N:
Management of hepatic metastasis from colorectal cancers: An
update. J Hepatobiliary Pancreat Surg. 15:570–580. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zakaria S, Donohue JH, Que FG, Farnell MB,
Schleck CD, Ilstrup DM and Nagorney DM: Hepatic resection for
colorectal metastases: Value for risk scoring systems? Ann Surg.
246:183–191. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Leonard GD, Brenner B and Kemeny NE:
Neoadjuvant chemotherapy before liver resection for patients with
unresectable liver metastases from colorectal carcinoma. J Clin
Oncol. 23:2038–2048. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Scheithauer W, Rosen H, Kornek GV, Sebesta
C and Depisch D: Randomised comparison of combination chemotherapy
plus supportive care with supportive care alone in patients with
metastatic colorectal cancer. BMJ. 306:752–755. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Saltz LB, Cox JV, Blanke C, Rosen LS,
Fehrenbacher L, Moore MJ, Maroun JA, Ackland SP, Locker PK, Pirotta
N, et al: Irinotecan Study Group: Irinotecan plus fluorouracil and
leucovorin for metastatic colorectal cancer. N Engl J Med.
343:905–914. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
de Gramont A, Figer A, Seymour M, Homerin
M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer
G, et al: Leucovorin and fluorouracil with or without oxaliplatin
as first-line treatment in advanced colorectal cancer. J Clin
Oncol. 18:2938–2947. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Aschele C, Cionini L, Lonardi S, Pinto C,
Cordio S, Rosati G, Artale S, Tagliagambe A, Ambrosini G, Rosetti
P, et al: Primary tumor response to preoperative chemoradiation
with or without oxaliplatin in locally advanced rectal cancer:
Pathologic results of the STAR-01 randomized phase III trial. J
Clin Oncol. 29:2773–2780. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Rödel C, Liersch T, Becker H, Fietkau R,
Hohenberger W, Hothorn T, Graeven U, Arnold D, Lang-Welzenbach M,
Raab HR, et al: German Rectal Cancer Study Group: Preoperative
chemoradiotherapy and postoperative chemotherapy with fluorouracil
and oxaliplatin versus fluorouracil alone in locally advanced
rectal cancer: Initial results of the German CAO/ARO/AIO-04
randomised phase 3 trial. Lancet Oncol. 13:679–687. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Allegra CJ, Yothers G, O'Connell MJ, Beart
RW, Wozniak TF, Pitot HC, Shields AF, Landry JC, Ryan DP, Arora A,
et al: Neoadjuvant 5-FU or capecitabine plus radiation with or
without oxaliplatin in rectal cancer patients: A phase III
randomized clinical trial. J Natl Cancer Inst. 107:pii: djv248.
2015. View Article : Google Scholar :
|
|
60
|
Schmoll H-J, Haustermans K, Price TJ,
Nordlinger B, Hofheinz R, Daisne J-F, Janssens J, Brenner B,
Schmidt P, Reinel H, et al: Preoperative chemoradiotherapy and
postoperative chemotherapy with capecitabine and oxaliplatin versus
capecitabine alone in locally advanced rectal cancer: First results
of the PETACC-6 randomized phase III trial. J Clin Oncol.
31:(Suppl). 35312013.PubMed/NCBI
|
|
61
|
Gérard JP, Azria D, Gourgou-Bourgade S,
Martel-Laffay I, Hennequin C, Etienne PL, Vendrely V, François E,
de La Roche G, Bouché O, et al: Comparison of two neoadjuvant
chemoradiotherapy regimens for locally advanced rectal cancer:
Results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin
Oncol. 28:1638–1644. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
An X, Lin X, Wang FH, Goodman K, Cai PQ,
Kong LH, Fang YJ, Gao YH, Lin JZ, Wan DS, et al: Short term results
of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in
combination with oxaliplatin in locally advanced rectal cancer: A
meta analysis. Eur J Cancer. 49:843–851. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Razafindratsira T, Isambert M and Evrard
S: Complications of intraoperative radiofrequency ablation of liver
metastases. HPB (Oxford). 13:15–23. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Evrard S, Rivoire M, Arnaud J, Lermite E,
Bellera C, Fonck M, Becouarn Y, Lalet C, Puildo M and
Mathoulin-Pelissier S: Unresectable colorectal cancer liver
metastases treated by intraoperative radiofrequency ablation with
or without resection. Br J Surg. 99:558–565. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Tournigand C, André T, Achille E, Lledo G,
Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, et
al: FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced
colorectal cancer: A randomized GERCOR study. J Clin Oncol.
22:229–237. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Falcone A, Ricci S, Brunetti I, Pfanner E,
Allegrini G, Barbara C, Crinò L, Benedetti G, Evangelista W,
Fanchini L, et al: Gruppo Oncologico Nord Ovest: Phase III trial of
infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan
(FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and
irinotecan (FOLFIRI) as first-line treatment for metastatic
colorectal cancer: The Gruppo Oncologico Nord Ovest. J Clin Oncol.
25:1670–1676. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Saltz LB, Clarke S, Díaz-Rubio E,
Scheithauer W, Figer A, Wong R, Koski S, Lichinitser M, Yang TS,
Rivera F, et al: Bevacizumab in combination with oxaliplatin-based
chemotherapy as first-line therapy in metastatic colorectal cancer:
A randomized phase III study. J Clin Oncol. 26:2013–2019. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Bokemeyer C, Bondarenko I, Makhson A,
Hartmann JT, Aparicio J, de Braud F, Donea S, Ludwig H, Schuch G,
Stroh C, et al: Fluorouracil, leucovorin, and oxaliplatin with and
without cetuximab in the first-line treatment of metastatic
colorectal cancer. J Clin Oncol. 27:663–671. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Kim KH, Shin SJ, Cho MS, Ahn JB, Jung M,
Kim TI, Park YS, Kim H, Kim NK and Koom WS: A phase II study of
preoperative mFOLFOX6 with short-course radiotherapy in patients
with locally advanced rectal cancer and liver-only metastasis.
Radiother Oncol. 118:369–374. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Grothey A, Jordan K, Kellner O, Constantin
C, Dietrich G, Kroening H, Mantovani L, Schlichting C, Forstbauer H
and Schmoll H-J: Capecitabine/irinotecan (Capiri) and
capecitabine/oxaliplatin (CapOx) are active second-line protocols
in patients with advanced colorectal cancer (ACRC) after failure of
first-line combination therapy: results of a randomized phase II
study. J Clin Oncol. 22:(Suppl 14). 35342004. View Article : Google Scholar
|
|
71
|
Shimonov M, Hayat H, Chaitchik S, Brener
J, Schachter P and Czerniak A: Combined systemic chronotherapy and
hepatic artery infusion for the treatment of metastatic colorectal
cancer confined to the liver. Chemotherapy. 51:111–115. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Kelly RJ, Kemeny NE and Leonard GD:
Current strategies using hepatic arterial infusion chemotherapy for
the treatment of colorectal cancer. Clin Colorectal Cancer.
5:166–174. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Lévi F, Giacchetti S, Adam R, Zidani R,
Metzger G and Misset JL: Chronomodulation of chemotherapy against
metastatic colorectal cancer. Eur J Cancer. 31A:1264–1270. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Shin SJ, Yoon HI, Kim NK, Lee KY, Min BS,
Ahn JB, Keum KC and Koom WS: Upfront systemic chemotherapy and
preoperative short-course radiotherapy with delayed surgery for
locally advanced rectal cancer with distant metastases. Radiat
Oncol. 6:992011. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Radu C, Berglund A, Påhlman L and
Glimelius B: Short-course preoperative radiotherapy with delayed
surgery in rectal cancer - a retrospective study. Radiother Oncol.
87:343–349. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Yoon HI, Koom WS, Kim TH, Ahn JB, Jung M,
Kim TI, Kim H, Shin SJ and Kim NK: Upfront systemic chemotherapy
and short-course radiotherapy with delayed surgery for locally
advanced rectal cancer with distant metastases: Outcomes,
compliance, and favorable prognostic factors. PLoS One.
11:e01614752016. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Brooks AJ, Wang F, Alfredson M, Yan TD and
Morris DL: Synchronous liver resection and cryotherapy for
colorectal metastases: survival analysis. Surgeon. 3:265–268. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Kennedy JE, Wu F, ter Haar GR, Gleeson FV,
Phillips RR, Middleton MR and Cranston D: High-intensity focused
ultrasound for the treatment of liver tumours. Ultrasonics.
42:931–935. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Abdalla EK, Vauthey JN, Ellis LM, Ellis V,
Pollock R, Broglio KR, Hess K and Curley SA: Recurrence and
outcomes following hepatic resection, radiofrequency ablation, and
combined resection/ablation for colorectal liver metastases. Ann
Surg. 239:818–827. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Khatri VP, Chee KG and Petrelli NJ: Modern
multimodality approach to hepatic colorectal metastases: Solutions
and controversies. Surg Oncol. 16:71–83. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Qiu J, Chen S and Wu H: Long-term outcomes
after hepatic resection combined with radiofrequency ablation for
initially unresectable multiple and bilobar liver malignancies. J
Surg Res. 188:14–20. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Park MJ, Kim TH, Lee KM, Cheong JY and Kim
JK: Radiofrequency ablation of metastatic liver masses: Recurrence
patterns and prognostic factors based on radiologic features.
Hepatogastroenterology. 60:563–567. 2013.PubMed/NCBI
|
|
83
|
Hur H, Ko YT, Min BS, Kim KS, Choi JS,
Sohn SK, Cho CH, Ko HK, Lee JT and Kim NK: Comparative study of
resection and radiofrequency ablation in the treatment of solitary
colorectal liver metastases. Am J Surg. 197:728–736. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Mima K, Beppu T, Chikamoto A, Miyamoto Y,
Nakagawa S, Kuroki H, Okabe H, Hayashi H, Sakamoto Y, Watanabe M,
et al: Hepatic resection combined with radiofrequency ablation for
initially unresectable colorectal liver metastases after effective
chemotherapy is a safe procedure with a low incidence of local
recurrence. Int J Clin Oncol. 18:847–855. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Berber E, Pelley R and Siperstein AE:
Predictors of survival after radiofrequency thermal ablation of
colorectal cancer metastases to the liver: A prospective study. J
Clin Oncol. 23:1358–1364. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Solbiati L, Livraghi T, Goldberg SN,
Ierace T, Meloni F, Dellanoce M, Cova L, Halpern EF and Gazelle GS:
Percutaneous radio-frequency ablation of hepatic metastases from
colorectal cancer: Long-term results in 117 patients. Radiology.
221:159–166. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Mulier S, Ni Y, Jamart J, Ruers T, Marchal
G and Michel L: Local recurrence after hepatic radiofrequency
coagulation: Multivariate meta-analysis and review of contributing
factors. Ann Surg. 242:158–171. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Cirocchi R, Trastulli S, Boselli C,
Montedori A, Cavaliere D, Parisi A, Noya G and Abraha I:
Radiofrequency ablation in the treatment of liver metastases from
colorectal cancer. Cochrane Database Syst Rev. 6:CD0063172012.
|
|
89
|
Bipat S, van Leeuwen MS, Comans EF, Pijl
ME, Bossuyt PM, Zwinderman AH and Stoker J: Colorectal liver
metastases: CT, MR imaging, and PET for diagnosis - meta-analysis.
Radiology. 237:123–131. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Elias D, De Baere T, Roche A, Mducreux
Leclere J and Lasser P: During liver regeneration following right
portal embolization the growth rate of liver metastases is more
rapid than that of the liver parenchyma. Br J Surg. 86:784–788.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Denys A, Bize P, Demartines N, Deschamps F
and De Baere T: Cardiovascular and Interventional Radiological
Society of Europe: Quality improvement for portal vein
embolization. Cardiovasc Intervent Radiol. 33:452–456. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Abdalla EK, Bauer TW, Chun YS, D'Angelica
M, Kooby DA and Jarnagin WR: Locoregional surgical and
interventional therapies for advanced colorectal cancer liver
metastases: expert consensus statements. HPB (Oxford). 15:119–130.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Brouquet A, Abdalla EK, Kopetz S, Garrett
CR, Overman MJ, Eng C, Andreou A, Loyer EM, Madoff DC, Curley SA,
et al: High survival rate after two-stage resection of advanced
colorectal liver metastases: Response-based selection and complete
resection define outcome. J Clin Oncol. 29:1083–1090. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Narita M, Oussoultzoglou E, Jaeck D,
Fuchschuber P, Rosso E, Pessaux P, Marzano E and Bachellier P:
Two-stage hepatectomy for multiple bilobar colorectal liver
metastases. Br J Surg. 98:1463–1475. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Simoneau E, Aljiffry M, Salman A,
Abualhassan N, Cabrera T, Valenti D, El Baage A, Jamal M, Kavan P,
Al-Abbad S, et al: Portal vein embolization stimulates tumour
growth in patients with colorectal cancer liver metastases. HPB
(Oxford). 14:461–468. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Maggiori L, Bretagnol F, Sibert A, Paradis
V, Vilgrain V and Panis Y: Selective portal vein ligation and
embolization induce different tumoral responses in the rat liver.
Surgery. 149:496–503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Pamecha V, Levene A, Grillo F, Woodward N,
Dhillon A and Davidson BR: Effect of portal vein embolisation on
the growth rate of colorectal liver metastases. Br J Cancer.
100:617–622. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Zou RH, Li AH, Han F, Hong J, Li BK, Huang
W, Huang L and Yuan YF: Liver hypertrophy and accelerated growth of
implanted tumors in nonembolized liver of rabbit after left portal
vein embolization. J Surg Res. 178:255–263. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Vente MA, Wondergem M, van der Tweel I,
van den Bosch MA, Zonnenberg BA, Lam MG, van Het Schip AD and
Nijsen JF: Yttrium-90 microsphere radioembolization for the
treatment of liver malignancies: A structured meta-analysis. Eur
Radiol. 19:951–959. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
de Graaf W, van den Esschert JW, van
Lienden KP and van Gulik TM: Induction of tumor growth after
preoperative portal vein embolization: Is it a real problem? Ann
Surg Oncol. 16:423–430. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Schnitzbauer AA, Lang SA, Goessmann H,
Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T,
Goralcyk A, Hörbelt R, et al: Right portal vein ligation combined
with in situ splitting induces rapid left lateral liver lobe
hypertrophy enabling 2-staged extended right hepatic resection in
small-for-size settings. Ann Surg. 255:405–414. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Gauzolino R, Castagnet M, Blanleuil ML and
Richer JP: The ALPPS technique for bilateral colorectal metastases:
Three ‘variations on a theme’. Updates Surg. 65:141–148. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Honjo I, Suzuki T, Ozawa K, Takasan H,
Kitamura O and Ishikawa T: Ligation of a branch of the portal vein
for carcinoma of the liver. Am J Surg. 130:296–302. 1975.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Aussilhou B, Lesurtel M, Sauvanet A,
Farges O, Dokmak S, Goasguen N, Sibert A, Vilgrain V and Belghiti
J: Right portal vein ligation is as efficient as portal vein
embolization to induce hypertrophy of the left liver remnant. J
Gastrointest Surg. 12:297–303. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Robles R, Marín C, Lopez-Conesa A, Capel
A, Perez-Flores D and Parrilla P: Comparative study of right portal
vein ligation versus embolisation for induction of hypertrophy in
two-stage hepatectomy for multiple bilateral colorectal liver
metastases. Eur J Surg Oncol. 38:586–593. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Schadde E, Raptis DA, Schnitzbauer AA,
Ardiles V, Tschuor C, Lesurtel M, Abdalla EK, Hernandez-Alejandro
R, Jovine E, Machado M, et al: Prediction of mortality after ALPPS
Stage-1: An analysis of 320 patients from the International ALPPS
Registry. Ann Surg. 262:780–786. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Shindoh J, Vauthey JN, Zimmitti G, Curley
SA, Huang SY, Mahvash A, Gupta S, Wallace MJ and Aloia TA: Analysis
of the efficacy of portal vein embolization for patients with
extensive liver malignancy and very low future liver remnant
volume, including a comparison with the associating liver partition
with portal vein ligation for staged hepatectomy approach. J Am
Coll Surg. 217:126–134. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Pandanaboyana S, Bell R, Hidalgo E,
Toogood G, Prasad KR, Bartlett A and Lodge JP: A systematic review
and meta-analysis of portal vein ligation versus portal vein
embolization for elective liver resection. Surgery. 157:690–698.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Sun Z, Tang W, Sakamoto Y, Hasegawa K and
Kokudo N: A systematic review and meta-analysis of feasibility,
safety and efficacy of associating liver partition and portal vein
ligation for staged hepatectomy (ALPPS) versus two-stage
hepatectomy (TSH). Biosci Trends. 9:284–288. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Shteyer E, Liao Y, Muglia LJ, Hruz PW and
Rudnick DA: Disruption of hepatic adipogenesis is associated with
impaired liver regeneration in mice. Hepatology. 40:1322–1332.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Hoekstra LT, de Graaf W, Nibourg GA, Heger
M, Bennink RJ, Stieger B and van Gulik TM: Physiological and
biochemical basis of clinical liver function tests: A review. Ann
Surg. 257:27–36. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Guiu B, Bize P, Gunthern D, Demartines N,
Halkic N and Denys A: Portal vein embolization before right
hepatectomy: Improved results using n-butyl-cyanoacrylate compared
to microparticles plus coils. Cardiovasc Intervent Radiol.
36:1306–1312. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Eshmuminov D, Raptis DA, Linecker M,
Wirsching A, Lesurtel M and Clavien PA: Meta-analysis of
associating liver partition with portal vein ligation and portal
vein occlusion for two-stage hepatectomy. Br J Surg. 103:1768–1782.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Lau WY, Ho S, Leung TW, Chan M, Ho R,
Johnson PJ and Li AK: Selective internal radiation therapy for
nonresectable hepatocellular carcinoma with intraarterial infusion
of 90yttrium microspheres. Int J Radiat Oncol Biol Phys.
40:583–592. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Murthy R, Xiong H, Nunez R, Cohen AC,
Barron B, Szklaruk J, Madoff DC, Gupta S, Wallace MJ, Ahrar K, et
al: Yttrium 90 resin microspheres for the treatment of unresectable
colorectal hepatic metastases after failure of multiple
chemotherapy regimens: Preliminary results. J Vasc Interv Radiol.
16:937–945. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Welsh JS, Kennedy AS and Thomadsen B:
Selective Internal Radiation Therapy (SIRT) for liver metastases
secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol
Phys. 66:(Suppl). S62–S73. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Van Hazel G, Blackwell A, Anderson J,
Price D, Moroz P, Bower G, Cardaci G and Gray B: Randomised phase 2
trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy
versus fluorouracil/leucovorin chemotherapy alone in advanced
colorectal cancer. J Surg Oncol. 88:78–85. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Van Hazel GA, Heinemann V, Sharma NK,
Findlay MP, Ricke J, Peeters M, Perez D, Robinson BA, Strickland
AH, Ferguson T, et al: SIRFLOX: Randomized phase III trial
comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus
mFOLFOX6 (plus or minus bevacizumab) plus selective internal
radiation therapy in patients with metastatic colorectal cancer. J
Clin Oncol. 34:1723–1731. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Bokemeyer C, Van Cutsem E, Rougier P,
Ciardiello F, Heeger S, Schlichting M, Celik I and Köhne CH:
Addition of cetuximab to chemotherapy as first-line treatment for
KRAS wild-type metastatic colorectal cancer: Pooled analysis of the
CRYSTAL and OPUS randomised clinical trials. Eur J Cancer.
48:1466–1475. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Sharma RA, Van Hazel GA, Morgan B, Berry
DP, Blanshard K, Price D, Bower G, Shannon JA, Gibbs P and Steward
WP: Radioembolization of liver metastases from colorectal cancer
using yttrium-90 microspheres with concomitant systemic
oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin
Oncol. 25:1099–1106. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Stubbs RS and Wickremesekera SK: Selective
internal radiation therapy (SIRT): A new modality for treating
patients with colorectal liver metastases. HPB (Oxford). 6:133–139.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Nordlinger B, Sorbye H, Glimelius B,
Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole
ET, Finch-Jones M, et al: EORTC Gastro-Intestinal Tract Cancer
Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen
und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie
(ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG);
Fédération Francophone de Cancérologie Digestive (FFCD):
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone
for resectable liver metastases from colorectal cancer (EORTC
40983): Long-term results of a randomised, controlled, phase 3
trial. Lancet Oncol. 14:1208–1215. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Ychou M, Hohenberger W, Thezenas S,
Navarro M, Maurel J, Bokemeyer C, Shacham-Shmueli E, Rivera F, Choi
Kwok-Keung C and Santoro A: A randomized phase III study comparing
adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients
following complete resection of liver metastases from colorectal
cancer. Ann Oncol. 20:1964–1970. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Portier G, Elias D, Bouche O, Rougier P,
Bosset JF, Saric J, Belghiti J, Piedbois P, Guimbaud R, Nordlinger
B, et al: Multicenter randomized trial of adjuvant fluorouracil and
folinic acid compared with surgery alone after resection of
colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin
Oncol. 24:4976–4982. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Hatfield P, Hingorani M, Radhakrishna G,
Cooper R, Melcher A, Crellin A, Kwok-Williams M and
Sebag-Montefiore D: Short-course radiotherapy, with elective delay
prior to surgery, in patients with unresectable rectal cancer who
have poor performance status or significant co-morbidity. Radiother
Oncol. 92:210–214. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Pettersson D, Holm T, Iversen H, Blomqvist
L, Glimelius B and Martling A: Preoperative short-course
radiotherapy with delayed surgery in primary rectal cancer. Br J
Surg. 99:577–583. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Turkmen C, Ucar A, Poyanli A, Vatankulu B,
Ozkan G, Basaran M, Serin K, Sanli Y and Adalet I: Initial outcome
after selective intraarterial radionuclide therapy with yttrium-90
microspheres as salvage therapy for unresectable metastatic liver
disease. Cancer Biother Radiopharm. 28:534–540. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Kucuk ON, Soydal C, Lacin S, Ozkan E and
Bilgic S: Selective intraarterial radionuclide therapy with
Yttrium-90 (Y-90) microspheres for unresectable primary and
metastatic liver tumors. World J Surg Oncol. 9:862011. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Björnsson B, Sparrelid E, Røsok B,
Pomianowska E, Hasselgren K, Gasslander T, Bjørnbeth BA, Isaksson B
and Sandström P: Associating liver partition and portal vein
ligation for staged hepatectomy in patients with colorectal liver
metastases - Intermediate oncological results. Eur J Surg Oncol.
42:531–537. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Kremer M, Manzini G, Hristov B,
Polychronidis G, Mokry T, Sommer CM, Mehrabi A, Weitz J, Büchler MW
and Schemmer P: Impact of neoadjuvant chemotherapy on hypertrophy
of the future liver remnant after associating liver partition and
portal vein ligation for staged hepatectomy. J Am Coll Surg.
221:717–728.e1. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Torres OJ, Fernandes ES, Oliveira CV, Lima
CX, Waechter FL, Moraes-Junior JM, Linhares MM, Pinto RD, Herman P
and Machado MA: Associating liver partition and portal vein
ligation for staged hepatectomy (ALPPS): The Brazilian experience.
Arq Bras Cir Dig. 26:40–43. 2013. View Article : Google Scholar : PubMed/NCBI
|
